Skip to main content

D. Pharm - II Examination - 2015 (I) | HOSPITAL & CLINICAL PHARMACY (THEORY)

 

ODISHA STATE BOARD OF PHARMACY

D. Pharm - II Examination - 2015 (I) 

HOSPITAL & CLINICAL PHARMACY  (THEORY) 

Time - 3 Hours                              Full Marks - 80

__________________


(Answer any five questions including question no-1)

1.(A) Define the following terms.

2x5

(i) Hospital

(ii) Drug Tolerance

(iii) Satellite Pharmacy

(iv) Inventory control

(v) Narcotic drugs.

(B) Write the full form of following abbreviation. 

1x10

(i) C.U.D.D

(ii) C.M.O

(iii) D.LC

(iv) P.T.C

(V) L.V.P

(vi) L.D.H

(vii) E.S.R

(viii) M.R.I 

(ix) N.S.A.L.D.S

(x) S.GO.T

2. (a) Describe the functions and objectives of hospital pharmacy services.

10

(b) Write about location and layout of a typical hospital pharmacy and give a diagram for flow chart of materials.

5

3.(a) Write about the facilities and requirements of sterile manufacture.

8

(b) Discuss about the layout of sterile products area.

7

4. Write notes on.

(a) Pharmacist and patient counseling.

8

(b) Factors causing non-compliance.

7

5. (a) Explain in detail on the drug distribution system to outpatients.

10

(b) Write about location and layout of outpatient dispensing along with figure.

5

6. Write pathophysiology and clinical manifestation of the following diseases. (any two)

7.5x2

(i) Hepatities

(ii) Epilepsy

(iii) Arrrythmia

7. Write notes on (any three)

15x3

(i) Teratogenecity

(ii) Medical complications and treatment of addictive drug alcohol.

(iii) Hypersensitivity

(iv) Application of computer in hospital pharmacy.



















Comments

Popular posts from this blog

Sukhi Tablet

  Sukhi Tablet COMPOSITION: Each film coated tablet contains : Levonorgestrel IP.       0.15 my Ethinylestradiol IP.      0.03 mg Excipients.                    q.s Colour : Titanium Dioxide IP Each film coated tablet contains : Ferrous Fumarate IP:         75 mg Equivalent to Ferrous Iron:  24.375 mg. Colour: Sunset Yellow FCF, Ponceau 4R Briliant Blue FCF (IS:5346) Storage instructions:   Store at cool & dry place, Protect from light and moisture. Keep all medicines out of reach of children. What is Try Sukhi Tablet? Try Sukhi is an oral contraceptive pill. This pill is an easy, safe, effective and reversible contraceptive for a woman wanting to delay her first pregnancy or space the next child. It is the method of choice for postponing the first pregnancy. Each packet of Try Sukhi contains one month supply. Each packet has 28 tablets. The first 21 tablets a...

Prescription (Chapter-1) | Pharmaceutics-II

  Chapter-1                       PRESCR IPTION DEFINITION • Prescription is a written order from a registered medical practitioner or another properly licensed practitioner such as dentist, doctor, veterinarian, etc to a pharmacist to compound and dispensed a specific medication for the patient. • The prescription also contains the direction for the patients regarding the mode of administration of drugs which dispensed to him. • Thus prescription is a medium through which treatment is provided to patients by both the physician and pharmacist. • The prescriptions are generally written in the English language but Latin words or abbreviations are frequently used in order to save time. PART OF A PRESCRIPTION Prescriptions are generally written on a typical format which are usually kept as pads. A typical prescription consists of following parts:-      1. Date      2. Name, age, sex and address...

CANDIFORCE-200: Composition, Description, Pharmacological Action, Precaution, Adverse Effects, Dosage, Storage, Uses

                  CANDIFORCE - 200                     Itraconazole Capsules BP           ______________________________________ COMPOSITION : Each HPMC capsule contains  Itraconazole BP                200 mg Excipients q.s. Approved colors used in the capsule shells. (Carmoisine, Ponceau-4R & Titanium Dioxide IP) DESCRIPTION:     Itraconazole is a synthetic triazole antifungal agent. Itraconazole is indicated for the treatment of the fungal infections in immunocompromised and non-immunocompromised patients. PHARMACOLOGICAL ACTION: 1.PHARMACODYNAMIC / MECHANISM OF ACTION :           In vitro studies have demonstrated that itraconazole inhibits the cytochrome P450-dependent synthesis of ergosterol, which is a vital component of fungal cell membr...